FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

732936001: Tablet (unit of presentation)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498397012 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498397012 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3357851001000118 Tablette de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
799361000241114 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
799361000241114 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
3357851001000118 Tablette de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tablet (unit of presentation) Is a Unit of presentation (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Venlafaxine (as venlafaxine hydrochloride) 25 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Venlafaxine (as venlafaxine hydrochloride) 25 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely venlafaxine (as venlafaxine hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely venlafaxine (as venlafaxine hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Aliskiren (as aliskiren fumarate) 300 mg and valsartan 320 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Aliskiren (as aliskiren fumarate) 300 mg and valsartan 320 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Aliskiren (as aliskiren fumarate) 300 mg and valsartan 320 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Pilocarpine hydrochloride 7.5 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Pilocarpine hydrochloride 7.5 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 45 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 45 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 45 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely seratrodast 80 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely seratrodast 80 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dicycloverine hydrochloride 10 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely dicycloverine hydrochloride 10 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dicycloverine hydrochloride 10 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atenolol 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atenolol 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atenolol 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Citicoline (as citicoline sodium) 500 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Citicoline (as citicoline sodium) 500 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely cefuroxime (as cefuroxime axetil) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cefuroxime (as cefuroxime axetil) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely cefuroxime (as cefuroxime axetil) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely mefenamic acid 500 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely mefenamic acid 500 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely mefenamic acid 500 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Atorvastatin (as atorvastatin calcium) 10 mg and fenofibrate 160 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Atorvastatin (as atorvastatin calcium) 10 mg and fenofibrate 160 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Atorvastatin (as atorvastatin calcium) 10 mg and fenofibrate 160 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely hydrochlorothiazide 12.5 milligram and nebivolol (as nebivolol hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and nebivolol (as nebivolol hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrochlorothiazide 12.5 milligram and nebivolol (as nebivolol hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely piroxicam 20 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely piroxicam 20 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Carbinoxamine maleate 4 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Carbinoxamine maleate 4 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely naproxen (as naproxen sodium) 500 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely naproxen (as naproxen sodium) 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely naproxen (as naproxen sodium) 250 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely naproxen (as naproxen sodium) 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely naproxen (as naproxen sodium) 375 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely naproxen (as naproxen sodium) 375 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Naproxen (as naproxen sodium) 200 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Naproxen (as naproxen sodium) 200 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin hydrochloride 500 mg and voglibose 200 microgram oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 500 mg and voglibose 200 microgram oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 500 mg and voglibose 200 microgram oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely cefalexin 500 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cefalexin 500 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely flavoxate hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely flavoxate hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Chlordiazepoxide 5 mg and clidinium bromide 2.5 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Chlordiazepoxide 5 mg and clidinium bromide 2.5 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Chlordiazepoxide 5 mg and clidinium bromide 2.5 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Amlodipine (as amlodipine besilate) 5 mg and lisinopril 5 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Amlodipine (as amlodipine besilate) 5 mg and lisinopril 5 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Amlodipine (as amlodipine besilate) 5 mg and lisinopril 5 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely etofylline 77 milligram and theophylline anhydrous 23 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely etofylline 77 milligram and theophylline anhydrous 23 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely etofylline 77 milligram and theophylline anhydrous 23 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely lamotrigine 25 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely lamotrigine 25 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Lamotrigine 50 mg prolonged-release oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Lamotrigine 50 mg prolonged-release oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Lamotrigine 200 mg prolonged-release oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Lamotrigine 200 mg prolonged-release oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely lamotrigine 300 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely lamotrigine 300 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Lamotrigine 100 mg prolonged-release oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Lamotrigine 100 mg prolonged-release oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1

Start Previous Page 79 of 87 Next End

This concept is not in any reference sets

Back to Start